Matt Kaeberlein
American biologist
Common Themes
Videos Mentioning Matt Kaeberlein
Balaji Srinivasan — How to Start a New Country
Tim Ferriss
Future guest on Tim Ferriss Show, who will discuss the balance between anabolism and longevity.
AMA #12: Thoughts on Longevity Supplements (Resveratrol, NR, NMN, Etc.) & How to Improve Memory
Andrew Huberman
An expert who debates NAD+ pathways and researches Rapamycin for lifespan extension, including a dog longevity project.
357 ‒ A new era of longevity science: models of aging, rapamycin trials, biological clocks, & more
Peter Attia MD
A collaborator and researcher in the aging field, often debated with by the speaker regarding intervention effects and known for demonstrating the unreliability of commercial epigenetic clocks.
175 - The biology of aging, rapamycin, and other interventions that target the aging process
Peter Attia MD
A guest on The Drive podcast, a professor at the University of Washington, and a leading expert in the biology of aging, discussing his research on mTOR, rapamycin, and the Dog Aging Project.
#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19
Peter Attia MD
A researcher who has advocated for more resources into exploring rapalogs for Alzheimer's disease due to their potential in ameliorating protein aggregation.
#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging
Peter Attia MD
Another leading researcher in the field of aging and Rapamycin, mentioned for his work on Rapamycin in dogs.
The Life-Extension Episode With Dr. Matt Kaeberlein | The Tim Ferriss Show
Tim Ferriss
Professor of Laboratory Medicine and Pathology at the University of Washington School of Medicine, focusing on biological mechanisms of aging to promote healthspan.
Dr. Peter Attia — Longevity Drugs, Alzheimer's Disease, and More
Tim Ferriss
Researcher studying Rapamycin in companion dogs, observing improvements in heart function and mitigating heart failure and cancer, though research is limited by funding.
#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the ITP
Peter Attia MD
A friend of Dr. Miller, conducting an important study giving Rapamycin to dogs.
#27 – David Sinclair, Ph.D.: Slowing aging – sirtuins, NAD, and the epigenetics of aging
Peter Attia MD
An incoming graduate student in Lenny Guarente's lab who performed the experiment showing that overexpressing the sirtuin gene in yeast cells extended their lifespan.
#10 – Matt Kaeberlein, Ph.D.: rapamycin and dogs — living longer, healthier & turning back the clock
Peter Attia MD
Guest on the podcast, recognized globally for his research in the biology of aging and director of the Dog Aging Project.
#02 – Rhonda Patrick, Ph.D.: paradox of IGF-1, ketogenic diets and genetics, benefits of sauna, NAD+
Peter Attia MD
A researcher at the University of Washington known for administering Rapamycin to pet dogs to study its effects on lifespan and age-related diseases like cardiomyopathy and cancer.
Supplements for Longevity & Their Efficacy | Dr. Peter Attia
Andrew Huberman
Researcher leading the Dog Aging Study, investigating the effects of rapamycin in higher-order mammals.
202 - Peter on nutrition, disease prevention, and more — looking back on the last 100 episodes
Peter Attia MD
A past guest who will return for a future AMA episode to provide a deep dive into research on NAD+, Metformin, and Rapamycin.